Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypothyroidism | 34 | 2023 | 659 | 9.680 |
Why?
|
Thyroxine | 34 | 2023 | 666 | 8.940 |
Why?
|
Thyroid Gland | 15 | 2021 | 1172 | 2.560 |
Why?
|
Thyrotropin | 18 | 2023 | 850 | 2.210 |
Why?
|
Triiodothyronine | 12 | 2023 | 494 | 1.870 |
Why?
|
Thyroid Hormones | 11 | 2023 | 390 | 1.770 |
Why?
|
Thyroid Diseases | 6 | 2018 | 378 | 1.750 |
Why?
|
Thyroid Nodule | 7 | 2021 | 750 | 1.540 |
Why?
|
Iodine Radioisotopes | 11 | 2015 | 1030 | 1.520 |
Why?
|
Thyroid Function Tests | 11 | 2021 | 284 | 1.480 |
Why?
|
Thyroid Neoplasms | 11 | 2021 | 2274 | 1.260 |
Why?
|
Hormone Replacement Therapy | 6 | 2018 | 744 | 1.260 |
Why?
|
Drugs, Generic | 3 | 2022 | 422 | 1.090 |
Why?
|
Tissue Extracts | 2 | 2017 | 135 | 1.090 |
Why?
|
Biopsy, Fine-Needle | 8 | 2021 | 1093 | 0.980 |
Why?
|
Endocrinology | 5 | 2019 | 443 | 0.840 |
Why?
|
Iodine | 3 | 2015 | 285 | 0.750 |
Why?
|
Thyrotoxicosis | 5 | 2016 | 82 | 0.740 |
Why?
|
Hyperthyroidism | 5 | 2013 | 293 | 0.670 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2018 | 101 | 0.640 |
Why?
|
Graves Disease | 5 | 2013 | 241 | 0.550 |
Why?
|
Therapeutic Equivalency | 6 | 2022 | 145 | 0.520 |
Why?
|
Congenital Hypothyroidism | 1 | 2013 | 39 | 0.440 |
Why?
|
Lubricants | 1 | 2012 | 31 | 0.440 |
Why?
|
Mass Screening | 4 | 2016 | 5238 | 0.420 |
Why?
|
Adenocarcinoma, Follicular | 3 | 2021 | 324 | 0.400 |
Why?
|
Biopsy, Needle | 2 | 2012 | 1640 | 0.400 |
Why?
|
Thyroiditis | 1 | 2011 | 85 | 0.390 |
Why?
|
Disease Management | 3 | 2015 | 2450 | 0.350 |
Why?
|
Vaginal Smears | 1 | 2012 | 511 | 0.350 |
Why?
|
Documentation | 1 | 2015 | 865 | 0.340 |
Why?
|
Receptors, Thyrotropin | 1 | 2009 | 45 | 0.340 |
Why?
|
History, 19th Century | 3 | 2019 | 720 | 0.340 |
Why?
|
Humans | 85 | 2023 | 742088 | 0.320 |
Why?
|
Radiation Protection | 1 | 2012 | 419 | 0.320 |
Why?
|
History, 21st Century | 4 | 2019 | 1533 | 0.320 |
Why?
|
Cytodiagnosis | 3 | 2021 | 435 | 0.310 |
Why?
|
Drug Compounding | 2 | 2020 | 242 | 0.310 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8425 | 0.300 |
Why?
|
Carcinoma | 2 | 2016 | 2374 | 0.300 |
Why?
|
Veterans | 1 | 2020 | 2513 | 0.290 |
Why?
|
Practice Guidelines as Topic | 6 | 2018 | 7276 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2195 | 0.280 |
Why?
|
Lithium Compounds | 1 | 2008 | 225 | 0.280 |
Why?
|
History, 20th Century | 4 | 2019 | 2739 | 0.280 |
Why?
|
Carcinoma, Papillary | 4 | 2021 | 781 | 0.280 |
Why?
|
Tomography, Emission-Computed | 1 | 2009 | 1144 | 0.270 |
Why?
|
Depressive Disorder | 1 | 2018 | 3748 | 0.260 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2211 | 0.260 |
Why?
|
Evidence-Based Medicine | 2 | 2016 | 3611 | 0.260 |
Why?
|
United States Food and Drug Administration | 5 | 2019 | 1581 | 0.250 |
Why?
|
Goiter | 2 | 2013 | 86 | 0.230 |
Why?
|
Atherosclerosis | 1 | 2020 | 3428 | 0.230 |
Why?
|
Drug Therapy | 1 | 2006 | 497 | 0.230 |
Why?
|
Muscle Weakness | 2 | 2005 | 414 | 0.210 |
Why?
|
Renal Insufficiency | 1 | 2008 | 802 | 0.210 |
Why?
|
Epitopes | 1 | 2009 | 2569 | 0.210 |
Why?
|
Carnitine | 2 | 2005 | 239 | 0.200 |
Why?
|
Iodide Peroxidase | 1 | 2023 | 293 | 0.200 |
Why?
|
Growth Hormone | 2 | 2001 | 703 | 0.200 |
Why?
|
Diet | 3 | 2015 | 7923 | 0.200 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2021 | 84 | 0.190 |
Why?
|
Dosage Forms | 1 | 2020 | 56 | 0.190 |
Why?
|
Quality Improvement | 1 | 2016 | 3738 | 0.190 |
Why?
|
Weight Lifting | 1 | 2001 | 131 | 0.190 |
Why?
|
Drug Administration Routes | 1 | 2020 | 153 | 0.190 |
Why?
|
Endocrine Glands | 1 | 2010 | 103 | 0.190 |
Why?
|
Chemistry, Pharmaceutical | 3 | 2008 | 282 | 0.180 |
Why?
|
Tablets | 1 | 2020 | 147 | 0.180 |
Why?
|
Egypt | 1 | 2020 | 100 | 0.180 |
Why?
|
Clinical Medicine | 1 | 2021 | 147 | 0.180 |
Why?
|
Drug Substitution | 1 | 2022 | 281 | 0.180 |
Why?
|
Gels | 1 | 2020 | 427 | 0.170 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2019 | 60 | 0.170 |
Why?
|
Endocrine System Diseases | 1 | 2010 | 248 | 0.160 |
Why?
|
Retrospective Studies | 8 | 2021 | 77098 | 0.150 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2001 | 555 | 0.150 |
Why?
|
Potassium Iodide | 1 | 2017 | 13 | 0.150 |
Why?
|
Radioactive Hazard Release | 1 | 2017 | 14 | 0.150 |
Why?
|
Drug Therapy, Combination | 3 | 2018 | 6483 | 0.150 |
Why?
|
Creatinine | 2 | 2004 | 1916 | 0.150 |
Why?
|
Thyroid (USP) | 1 | 2016 | 3 | 0.150 |
Why?
|
Pituitary Neoplasms | 2 | 1996 | 1340 | 0.150 |
Why?
|
Immunoassay | 1 | 2020 | 752 | 0.150 |
Why?
|
Intestinal Absorption | 1 | 2018 | 420 | 0.150 |
Why?
|
Hashimoto Disease | 2 | 2013 | 93 | 0.140 |
Why?
|
Frail Elderly | 1 | 2001 | 691 | 0.140 |
Why?
|
Goals | 1 | 2021 | 705 | 0.140 |
Why?
|
Fasting | 2 | 2020 | 1589 | 0.140 |
Why?
|
Suction | 1 | 1997 | 267 | 0.140 |
Why?
|
Managed Care Programs | 1 | 2021 | 949 | 0.140 |
Why?
|
Societies, Scientific | 1 | 2016 | 220 | 0.130 |
Why?
|
Adrenocorticotropic Hormone | 1 | 1997 | 648 | 0.130 |
Why?
|
Milk | 1 | 2018 | 449 | 0.130 |
Why?
|
Female | 33 | 2021 | 379592 | 0.130 |
Why?
|
Oxyphil Cells | 1 | 2015 | 57 | 0.130 |
Why?
|
United States | 12 | 2019 | 69693 | 0.130 |
Why?
|
History, Ancient | 1 | 2015 | 212 | 0.130 |
Why?
|
Male | 27 | 2021 | 349538 | 0.120 |
Why?
|
Exercise Therapy | 1 | 2001 | 904 | 0.120 |
Why?
|
Biological Availability | 2 | 2006 | 396 | 0.120 |
Why?
|
Glyburide | 1 | 1994 | 113 | 0.120 |
Why?
|
Societies, Medical | 4 | 2018 | 3740 | 0.120 |
Why?
|
Preventive Medicine | 1 | 2016 | 263 | 0.120 |
Why?
|
Mental Disorders | 1 | 2013 | 6587 | 0.110 |
Why?
|
Ultrasonography | 2 | 2020 | 5978 | 0.110 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2017 | 469 | 0.110 |
Why?
|
Aged | 17 | 2021 | 162944 | 0.110 |
Why?
|
Biological Assay | 1 | 2016 | 652 | 0.110 |
Why?
|
Diabetic Angiopathies | 1 | 1998 | 820 | 0.110 |
Why?
|
Adult | 22 | 2021 | 213712 | 0.110 |
Why?
|
Thyroidectomy | 2 | 2016 | 877 | 0.110 |
Why?
|
Eating | 1 | 2020 | 1535 | 0.110 |
Why?
|
Middle Aged | 20 | 2021 | 213127 | 0.110 |
Why?
|
Administration, Oral | 1 | 2020 | 3913 | 0.110 |
Why?
|
Data Collection | 2 | 2014 | 3339 | 0.110 |
Why?
|
Thermogenesis | 1 | 2016 | 429 | 0.110 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2275 | 0.110 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 552 | 0.110 |
Why?
|
Muscles | 1 | 1997 | 1617 | 0.100 |
Why?
|
Acromegaly | 1 | 1995 | 347 | 0.100 |
Why?
|
Drug Interactions | 1 | 2016 | 1458 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 1998 | 1499 | 0.100 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2015 | 325 | 0.100 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10163 | 0.100 |
Why?
|
Disease Progression | 3 | 2015 | 13256 | 0.100 |
Why?
|
Adipose Tissue, Brown | 1 | 2016 | 754 | 0.090 |
Why?
|
Diagnosis, Differential | 6 | 2019 | 12958 | 0.090 |
Why?
|
Guideline Adherence | 3 | 2019 | 2266 | 0.090 |
Why?
|
Nutrition Policy | 1 | 2014 | 488 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2019 | 2968 | 0.090 |
Why?
|
Ambulatory Care Facilities | 1 | 2016 | 932 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2023 | 19862 | 0.090 |
Why?
|
Combined Modality Therapy | 3 | 2015 | 8621 | 0.080 |
Why?
|
Morbidity | 1 | 2014 | 1767 | 0.080 |
Why?
|
Risk Factors | 5 | 2020 | 72145 | 0.080 |
Why?
|
Aged, 80 and over | 7 | 2021 | 57683 | 0.080 |
Why?
|
Genetic Testing | 1 | 2021 | 3439 | 0.080 |
Why?
|
Medical Audit | 1 | 2009 | 467 | 0.080 |
Why?
|
Hyperprolactinemia | 1 | 1988 | 129 | 0.080 |
Why?
|
Anxiety Disorders | 1 | 2018 | 2684 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2021 | 62966 | 0.070 |
Why?
|
Cost Savings | 1 | 2012 | 925 | 0.070 |
Why?
|
Drug Stability | 2 | 2008 | 290 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3548 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2019 | 15056 | 0.070 |
Why?
|
Pregnancy | 5 | 2021 | 29087 | 0.070 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1831 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3391 | 0.070 |
Why?
|
Adenoma | 1 | 1996 | 2168 | 0.070 |
Why?
|
Databases, Factual | 1 | 2020 | 7716 | 0.070 |
Why?
|
Mood Disorders | 1 | 2012 | 1106 | 0.060 |
Why?
|
Prognosis | 3 | 2016 | 29010 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7167 | 0.060 |
Why?
|
Family Practice | 1 | 2007 | 516 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 12730 | 0.060 |
Why?
|
Deficiency Diseases | 1 | 2004 | 72 | 0.060 |
Why?
|
Insurance Benefits | 1 | 2005 | 183 | 0.060 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2008 | 633 | 0.060 |
Why?
|
Legislation, Drug | 1 | 2005 | 206 | 0.060 |
Why?
|
Prevalence | 2 | 2019 | 15194 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2015 | 3294 | 0.050 |
Why?
|
Risk Assessment | 2 | 2021 | 23320 | 0.050 |
Why?
|
Depression | 2 | 2018 | 7733 | 0.050 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 2658 | 0.050 |
Why?
|
Age Factors | 2 | 2014 | 18355 | 0.050 |
Why?
|
Drug Approval | 1 | 2008 | 740 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2007 | 1459 | 0.050 |
Why?
|
Drug Monitoring | 1 | 2007 | 956 | 0.050 |
Why?
|
Muscular Diseases | 1 | 2005 | 557 | 0.050 |
Why?
|
Cohort Studies | 2 | 2020 | 40450 | 0.050 |
Why?
|
Animals | 5 | 2018 | 168561 | 0.040 |
Why?
|
Body Composition | 2 | 2001 | 2400 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2001 | 664 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 1998 | 6454 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2749 | 0.040 |
Why?
|
Prefrontal Cortex | 1 | 2008 | 2146 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15530 | 0.040 |
Why?
|
Nuclear Power Plants | 1 | 2017 | 7 | 0.040 |
Why?
|
Young Adult | 3 | 2016 | 56350 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2012 | 4030 | 0.040 |
Why?
|
Muscle, Skeletal | 2 | 2005 | 4933 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2007 | 12017 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10943 | 0.040 |
Why?
|
Drug Costs | 1 | 2005 | 1104 | 0.040 |
Why?
|
Artificial Organs | 1 | 1999 | 204 | 0.040 |
Why?
|
Body Weight | 2 | 2004 | 4664 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2004 | 6608 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2009 | 3527 | 0.030 |
Why?
|
Thyrotropin-Releasing Hormone | 2 | 1986 | 147 | 0.030 |
Why?
|
Paraneoplastic Endocrine Syndromes | 1 | 1995 | 31 | 0.030 |
Why?
|
Hormones, Ectopic | 1 | 1995 | 40 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 1999 | 545 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2009 | 2986 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2007 | 2838 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 1998 | 11695 | 0.030 |
Why?
|
Professional Competence | 1 | 2018 | 448 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 1999 | 2027 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2003 | 1071 | 0.030 |
Why?
|
Regression Analysis | 1 | 2004 | 6452 | 0.030 |
Why?
|
Advisory Committees | 1 | 2018 | 773 | 0.030 |
Why?
|
Adenoma, Oxyphilic | 1 | 2015 | 143 | 0.030 |
Why?
|
Insulin-Like Growth Factor II | 1 | 1995 | 271 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2001 | 1369 | 0.030 |
Why?
|
Biopsy | 2 | 2005 | 6756 | 0.030 |
Why?
|
Pituitary Gland | 1 | 1996 | 665 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2001 | 2014 | 0.030 |
Why?
|
Time Factors | 3 | 2004 | 40054 | 0.030 |
Why?
|
Adolescent | 5 | 2009 | 85649 | 0.030 |
Why?
|
Education, Medical, Continuing | 1 | 1998 | 839 | 0.030 |
Why?
|
Comorbidity | 1 | 2007 | 10372 | 0.030 |
Why?
|
Radiography | 1 | 2004 | 7010 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2001 | 6365 | 0.030 |
Why?
|
Postpartum Thyroiditis | 1 | 2011 | 1 | 0.030 |
Why?
|
Recurrence | 1 | 2004 | 8333 | 0.030 |
Why?
|
Disasters | 1 | 2017 | 510 | 0.020 |
Why?
|
Bipolar Disorder | 1 | 2008 | 5024 | 0.020 |
Why?
|
Fatigue | 1 | 2018 | 1526 | 0.020 |
Why?
|
Affect | 1 | 2018 | 1473 | 0.020 |
Why?
|
Pleural Neoplasms | 1 | 1995 | 607 | 0.020 |
Why?
|
Placebos | 1 | 1994 | 1677 | 0.020 |
Why?
|
Algorithms | 2 | 2007 | 13853 | 0.020 |
Why?
|
Pilot Projects | 2 | 2016 | 8297 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2013 | 3215 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2007 | 4628 | 0.020 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2009 | 52 | 0.020 |
Why?
|
Equipment Design | 1 | 1997 | 3582 | 0.020 |
Why?
|
Mesothelioma | 1 | 1995 | 818 | 0.020 |
Why?
|
Drug Storage | 1 | 2008 | 51 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2012 | 500 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2016 | 2013 | 0.020 |
Why?
|
Hypoglycemia | 1 | 1995 | 859 | 0.020 |
Why?
|
Alzheimer Disease | 1 | 2008 | 7988 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 310 | 0.020 |
Why?
|
Coronary Vessels | 1 | 1998 | 3099 | 0.020 |
Why?
|
Swine | 1 | 1997 | 5934 | 0.020 |
Why?
|
Life Style | 1 | 1998 | 3824 | 0.020 |
Why?
|
Models, Biological | 1 | 2013 | 9581 | 0.020 |
Why?
|
Emotions | 1 | 2018 | 2657 | 0.020 |
Why?
|
Body Surface Area | 1 | 1986 | 198 | 0.020 |
Why?
|
Internet | 1 | 2018 | 3062 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2016 | 2896 | 0.020 |
Why?
|
Autopsy | 1 | 2008 | 1006 | 0.020 |
Why?
|
Linear Models | 1 | 1995 | 5948 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3915 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 1994 | 2623 | 0.010 |
Why?
|
Consensus | 1 | 2012 | 2935 | 0.010 |
Why?
|
Drug Synergism | 1 | 2007 | 1791 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9679 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 1996 | 11001 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 15108 | 0.010 |
Why?
|
Public Health | 1 | 2014 | 2594 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1995 | 2861 | 0.010 |
Why?
|
Cognition | 1 | 2018 | 6722 | 0.010 |
Why?
|
Half-Life | 1 | 2001 | 658 | 0.010 |
Why?
|
Blood Glucose | 1 | 1994 | 6249 | 0.010 |
Why?
|
Physicians | 1 | 2018 | 4554 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1995 | 14720 | 0.010 |
Why?
|
Body Mass Index | 1 | 1997 | 12695 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6171 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9410 | 0.010 |
Why?
|
Hypertension | 1 | 1998 | 8455 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1999 | 918 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 3001 | 0.010 |
Why?
|
Psychotherapy | 1 | 2007 | 1644 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2007 | 6030 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1997 | 449 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2009 | 4379 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 1999 | 913 | 0.010 |
Why?
|
Patient Selection | 1 | 2007 | 4214 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 13029 | 0.010 |
Why?
|
Sex Factors | 1 | 1986 | 10392 | 0.010 |
Why?
|
Parity | 1 | 1995 | 929 | 0.010 |
Why?
|
Cell Division | 1 | 1999 | 4564 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 21719 | 0.010 |
Why?
|
Prospective Studies | 1 | 1995 | 53187 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 1996 | 35342 | 0.010 |
Why?
|
Aging | 1 | 1986 | 8626 | 0.000 |
Why?
|
Weight Gain | 1 | 1997 | 2282 | 0.000 |
Why?
|
Child | 1 | 1995 | 77478 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1999 | 11363 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1999 | 11470 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 1997 | 13921 | 0.000 |
Why?
|